Eurofins-Cerep

ALECR.PAPre-clinical

Le Bois l'Évêque, Franceeurofins.com

Eurofins-Cerep operates as a key contract research organization (CRO) within Eurofins Scientific, delivering critical preclinical data to accelerate client R&D programs. The company leverages extensive expertise in in vitro and in vivo pharmacology, pharmacokinetics, and toxicology to de-risk drug candidates. Its strategic position within Eurofins provides access to a vast network of complementary testing services, making it a one-stop partner for early-stage drug discovery and safety assessment.

Market Cap

$104.8M

Focus

Biotech

ALECR.PA · Stock Price

USD 18000.006200.00 (-25.62%)

Historical price data

AI Company Overview

Technology Platform

Integrated platform of over 800 validated in vitro assays for comprehensive pharmacology, ADME, and early toxicology profiling to support drug discovery and development.

Opportunities

Growth is driven by increased outsourcing from pharma and biotech, the rise of complex novel therapeutic modalities requiring specialized testing, and the ability to cross-sell services within the vast Eurofins Scientific global network.

Risk Factors

Key risks include intense competition from large and niche CROs, potential pricing pressure, dependence on the health of the biotech funding environment, and reputational risk associated with data quality.

Competitive Landscape

Competes with large full-service CROs (Charles River, Labcorp) and specialized discovery firms (Evotec, WuXi). Differentiation lies in its scientific reputation, deep assay portfolio, and integration with Eurofins' broader testing network.